Mark Wallet
Chief Scientific Officer Link Cell Therapies
Mark Wallet joined Link Cell Therapies in October 2024 as Chief Scientific Officer. Previously, he was VP and Head of Immuno-oncology at Century Therapeutics, leading preclinical development of gene-edited iPSC-derived CAR-NK and CAR-T cell therapies for cancer. Earlier, at Fate Therapeutics, he built the translational science team advancing allogeneic donor-derived NK and iPSC-derived cell therapies. He began his career as a faculty member at the University of Florida where his lab focused on immunogenetics research in autoimmunity and infectious disease. Mark holds a Ph.D. in Microbiology and Immunology from UNC Chapel Hill.
Seminars
Wednesday 16th September 2026
Engineering Gated CAR-Ts to Enhance Target Specificity & Combat the Solid Tumor Microenvironment
12:10 pm
- Designing logic gated CAR-T to overcome ontarget off-tumor toxicities in solid tumors
- Utilizing logic in vivo delivery platforms for logic gated CAR-T cells
- Discussing how logic gating enables armoring to enhance potency and overcome suppressive TME
